GRN and metabolic disease: Consequently, modulation of PGRN expression profiles in distinct tissues; comprehensive elucidation of its pathophysiological roles and molecular regulatory mechanisms in metabolic diseases; and development of tissue-targeted PGRN derivatives with enhanced specificity, may be a novel therapeutic strategy for the treatment of metabolic diseases.